The odds ratios we observed for HiQ-damaging and HiQ-tolerated variants are each similar to the confidence interval for breast cancer odds ratio (1.2–1.77) reported recently for CHEK2 missense variants in an overlapping cohort.55 Here, CHEK2 is linked to breast carcinoma.